Pancreatic Cancer Biomarkers and Their Implication in Cancer Diagnosis and Epidemiology
Pancreatic cancer is the fourth most common cause of cancer-related mortality in the United States. Biomarkers are needed to detect this cancer early during the disease development and for screening populations to identify those who are at risk. In cancer, “biomarker” refers to a substance or proces...
Main Author: | Mukesh Verma |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2010-11-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/2/4/1830/ |
Similar Items
-
Cancer Biomarkers: Are We Ready for the Prime Time?
by: Alok Mishra, et al.
Published: (2010-03-01) -
Biomarkers in Prostate Cancer Epidemiology
by: Mudit Verma, et al.
Published: (2011-09-01) -
Biomarker Panel for the Diagnosis of Pancreatic Ductal Adenocarcinoma
by: Hongbeom Kim, et al.
Published: (2020-06-01) -
Review of Immunohistochemistry Biomarkers in Pancreatic Cancer Diagnosis
by: Tuan Trong Luu
Published: (2021-12-01) -
Identification of differentially methylated genes as diagnostic and prognostic biomarkers of breast cancer
by: Xiao-hong Mao, et al.
Published: (2021-01-01)